Institutional Ownership
Sab Biotherapeutics Inc
CUSIP 78397T202COM NEWSABSQ1 2026
Institutional Holders
72
13F filers
Shares Held
65.72M
Aggregate institutional
Institutional Value
$251.50M
Q1 2026
Net New Holders
+26
32 new · 6 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions32
Increased23
Decreased6
Sold out6
Institutional Holders
72 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vivo Capital, LLC | 11.42M | $43.74M | 0 | Held |
| 2 | Caligan Partners LP | 7.97M | $30.51M | +7.97M | New |
| 3 | Perceptive Advisors LLC | 6.43M | $24.63M | +5.63M | Added |
| 4 | Ra Capital Management, L.P. | 4.40M | $16.86M | 0 | Held |
| 5 | Commodore Capital LP | 4.40M | $16.86M | 0 | Held |
| 6 | Balyasny Asset Management L.P. | 3.76M | $14.40M | +3.29M | Added |
| 7 | Adage Capital Partners Gp, L.L.C. | 3.41M | $13.04M | +3.41M | New |
| 8 | Millennium Management LLC | 3.03M | $11.62M | +2.71M | Added |
| 9 | Woodline Partners LP | 2.85M | $10.92M | +910 | Added |
| 10 | Spruce Street Capital LP | 2.20M | $8.42M | 0 | Held |
62 more institutional holders on Premium
See every fund holding Sab Biotherapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders